CANCER GENETICS, INC | Business Contracts

Description of Securities (Filed With SEC on March 31, 2023)

Share Purchase Agreement, dated March 13, 2023, by and between Vyant Bio, Inc. and Sabine Brandt as trustee for the Brandt Family Trust (Filed With SEC on March 15, 2023)

Share Purchase Agreement, dated December 30, 2022, by and between vivoPharm Pty, Ltd. and Sabine Brandt as trustee for the Brandt Family Trust (Filed With SEC on January 5, 2023)

Equity Purchase Agreement, dated November 2, 2022 by and among Vyant Bio, Inc., Reaction Biology Corporation and vivoPharm Pty, Ltd (Filed With SEC on November 3, 2022)

Equity Distribution Agreement, dated April 8, 2022, by and between Vyant Bio, Inc. and Canaccord Genuity LLC (Filed With SEC on April 11, 2022)

Description of Securities (Filed With SEC on March 30, 2022)

Employment Agreement, dated October 25, 2021, between the Company and Robert Fremeau (Filed With SEC on March 30, 2022)

Lease Agreement dated January 7, 2022 by and between StemoniX, Inc. and Nancy Ridge Technology Center, L.P (Filed With SEC on March 30, 2022)

Lease Agreement dated July 17, 2017 by and between StemoniX, Inc. and WBL Properties 1 LLC (Filed With SEC on March 30, 2022)

First Amendment to Lease dated August 10, 2020 by and between StemoniX, Inc. and WBL Properties 1 LLC (Filed With SEC on March 30, 2022)

Second Amendment to Lease dated September 29, 2020 by and between StemoniX, Inc. and WBL Properties 1 LLC (Filed With SEC on March 30, 2022)

Purchase Agreement dated March 28, 2022 between Lincoln Park Capital, LLC and Vyant Bio, Inc (Filed With SEC on March 30, 2022)

Registration Rights Agreement dated March 28, 2022 between Lincoln Park Capital, LLC and Vyant Bio, Inc (Filed With SEC on March 30, 2022)

Form of Exchange Warrant dated March 30, 2021 (Filed With SEC on April 5, 2021)

Vyant Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 5, 2021)

Form of Incentive Stock Option Grant Agreement (Filed With SEC on April 5, 2021)

Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on April 5, 2021)

Form of Stock Unit Award Agreement (Filed With SEC on April 5, 2021)

Employment Agreement, dated March 30, 2021, between the Company and Yung-Ping Yeh (Filed With SEC on April 5, 2021)

Employment Agreement, dated March 30, 2021, between the Company and Andrew D. C. LaFrence (Filed With SEC on April 5, 2021)

Amendment No. 1 to Employment Agreement, dated March 30, 2021, between the Company and John A. Roberts (Filed With SEC on April 5, 2021)

Description of Securities (Filed With SEC on March 31, 2021)

Amendment No. 2 to Agreement and Plan of Merger and Reorganization, by and among Cancer Genetics, Inc., StemoniX, Inc., and CGI Acquisition, Inc., dated February 26, 2021 (Filed With SEC on February 26, 2021)

Form of Wainwright Warrants dated February 16, 2021 (Filed With SEC on February 16, 2021)

Form of Securities Purchase Agreement, dated February 10, 2021 (Filed With SEC on February 16, 2021)

Form of Engagement Agreement, dated September 18, 2020, as amended (Filed With SEC on February 16, 2021)

Amendment No. 1 to Agreement and Plan of Merger and Reorganization, by and among Cancer Genetics, Inc., StemoniX, Inc., and CGI Acquisition, Inc., dated February 8, 2021 (Filed With SEC on February 8, 2021)

Form of Common Warrant (Filed With SEC on February 1, 2021)

Form of Placement Agent Warrants (Filed With SEC on February 1, 2021)

Form of Securities Purchase Agreement, dated January 28, 2021 (Filed With SEC on February 1, 2021)

Form of Registration Rights Agreement, dated January 28, 2021 (Filed With SEC on February 1, 2021)

At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020 (Filed With SEC on December 3, 2020)

Form of Warrant Exchange and Amendment Agreement, dated as of November 20, 2020, by and between Cancer Genetics, Inc. and the Holders (Filed With SEC on November 20, 2020)

Amended and Restated Underwriting Agreement, dated October 28, 2020, by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 2, 2020)

Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on November 2, 2020)

Agreement and Plan of Merger and Reorganization, by and among Cancer Genetics, Inc., StemoniX, Inc., and CGI Acquisition, Inc., dated August 21, 2020 (Filed With SEC on August 24, 2020)

Description of Securities (Filed With SEC on May 29, 2020)

Exhibit 4.1 Promissory Note with Atlas Sciences (Filed With SEC on October 25, 2019)

Exhibit 10.1 Note Purchase Agreement with Atlas Sciences (Filed With SEC on October 25, 2019)

Exhibit 10.2 Settlement Agreement with NovellusDx Ltd (Filed With SEC on October 25, 2019)

Asset Purchase Agreement, dated July 5, 2019, by and among siParadigm, LLC and Cancer Genetics, Inc (Filed With SEC on August 19, 2019)

Forbearance and Sixth Amendment to Amended and Restated Loan and Security Agreement, between Cancer Genetics, Inc. and Silicon Valley Bank, dated June 13, 2019 (Filed With SEC on August 19, 2019)

Promissory Note of Interpace BioPharma, Inc., dated July 15, 2019, in favor of Cancer Genetics, Inc (Filed With SEC on July 19, 2019)

Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc (Filed With SEC on July 19, 2019)

Secured Creditor Asset Purchase Agreement, dated July 15, 2019, by and among Interpace BioPharma, Inc., Cancer Genetics, Inc., Interpace Diagnostics Group, Inc. and Partners for... (Filed With SEC on July 19, 2019)

Standstill Agreement #2, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated May 3, 2019 (Filed With SEC on May 20, 2019)

Standstill Agreement, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated February 12, 2019 (Filed With SEC on April 16, 2019)

Employment Agreement with Ralf Brandt, dated August 15, 2017 (Filed With SEC on April 16, 2019)

Offer Letter with Michael McCartney, dated May 14, 2018 (Filed With SEC on April 16, 2019)

Offer Letter with William Finger, dated December 14, 2018 (Filed With SEC on April 16, 2019)

Form of Placement Agent Warrants of Cancer Genetics, Inc (Filed With SEC on January 29, 2019)

Forbearance and Fifth Amendment to Amended and Restated Loan and Security Agreement with Silicon Valley Bank, dated January 16, 2019 (Filed With SEC on January 16, 2019)

Forbearance Agreement and Modification No. 4 to Loan and Security Agreement with Partners for Growth IV, L.P., dated January 16, 2019 (Filed With SEC on January 16, 2019)

Underwriting Agreement, dated January 9, 2019, by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 10, 2019)

Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on January 10, 2019)

Offer Letter with Glenn Miles, dated November 16, 2018 (Filed With SEC on November 21, 2018)

Agreement and Plan of Merger, dated September 18, 2018, by and among Cancer Genetics, Inc., NovellusDx Ltd. and Wogolos Ltd (Filed With SEC on September 21, 2018)

Credit Agreement, dated September 18, 2018, by and between Cancer Genetics, Inc. and NovellusDx Ltd (Filed With SEC on September 21, 2018)

Promissory Note, dated September 18, 2018, in favor of NovellusDx Ltd (Filed With SEC on September 21, 2018)

Registration Rights Agreement, dated September 18, 2018, by and between Cancer Genetics, Inc. and NovellusDx Ltd (Filed With SEC on September 21, 2018)

Exhibit 10.1 Waiver and Third Amendment to Amended and Restated Loan and Security Agreement with Silicon Valley Bank, dated as of August 20, 2018 (Filed With SEC on August 21, 2018)

Exhibit 10.2 Waiver and Modification No. 3 to Loan and Security Agreement with Partners for Growth IV, L.P., dated as of August 20, 2018 (Filed With SEC on August 21, 2018)

Convertible Promissory Note (Filed With SEC on July 18, 2018)

Securities Purchase Agreement (Filed With SEC on July 18, 2018)

Omnibus Warrant Amendment to Warrant Issued to Lenders, dated as of June 30, 2018 (Filed With SEC on July 5, 2018)

Joinder and Modification No. 2 to Loan and Security Agreement with Partners for Growth IV, L.P., dated as of June 30, 2018 (Filed With SEC on July 5, 2018)

Exhibit 10.1 Joinder and Second Amendment to Amended and Restated Loan and Security Agreement with Silicon Valley Bank, dated as of June 21, 2018 (Filed With SEC on June 27, 2018)

Exhibit 10.1 Share Purchase Agreement dated April 26, 2018 by and among BioServe Biotechnologies (India) Private Limited, Cancer Genetics, Inc. and Reprocell Incorporated (Filed With SEC on April 27, 2018)

Form of Warrant Agreement of Cancer Genetics, Inc (Filed With SEC on December 8, 2017)

Form of Securities Purchase Agreement, dated December 8, 2017, by and between Cancer Genetics, Inc. and various purchasers named therein (Filed With SEC on December 8, 2017)

Engagement Letter between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated as of December 3, 2017 (Filed With SEC on December 8, 2017)

STOCK PURCHASE AGREEMENT among VIVOPHARM PTY. LTD. BRANDT FAMILY TRUST SOUTH AUSTRALIAN LIFE SCIENCE ADVANCEMENT PARTNERSHIP, LP ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY MANAGEMENT... (Filed With SEC on August 16, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 16, 2017)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 16, 2017)

CANCER GENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2017)

AMENDMENT TO AMENDED AND RESTATED CANCER GENETICS,INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on October 13, 2016)

CANCER GENETICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 9, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 9, 2016)

430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on September 9, 2016)

CANCER GENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 30, 2016)

CANCER GENETICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 20, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 20, 2016)

430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on May 20, 2016)

CANCER GENETICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on November 6, 2015)

CANCER GENETICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 6, 2015)

AMENDED AND RESTATED ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST... (Filed With SEC on August 21, 2015)

ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST 9, 2015 Table of... (Filed With SEC on August 10, 2015)

CANCER GENETICS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 16, 2015)

CANCER GENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on July 7, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 11, 2015)

CONSULTING AGREEMENT (Filed With SEC on November 13, 2014)

RECITALS: (Filed With SEC on November 13, 2014)

DATED MAY 12, 2014 SHARE PURCHASE AGREEMENT BY AND AMONGST CANCER GENETICS (INDIA) PRIVATE LIMITED AND RAMAKRISHNA VENKATASIVA MODALI AND NAGABHUSHANA SASTRY MODALI AND INVESTOR... (Filed With SEC on August 18, 2014)

STOCK PURCHASE AGREEMENT (Filed With SEC on August 18, 2014)

ASSET PURCHASE AGREEMENT (Filed With SEC on July 22, 2014)

AMENDED AND RESTATED CANCER GENETICS, INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on May 22, 2014)

Wells Fargo Bank, National Association (Filed With SEC on April 4, 2014)

CONSULTING AGREEMENT (Filed With SEC on March 28, 2014)

SEPARATION AND GENERAL RELEASE AGREEMENT (Filed With SEC on March 28, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 28, 2014)

UNDERWRITING AGREEMENT between CANCERGENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters CANCER GENETICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on October 21, 2013)

UNDERWRITING AGREEMENT between CANCER GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters CANCER GENETICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 14, 2013)

UNDERWRITING AGREEMENT between CANCER GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters CANCER GENETICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on July 12, 2013)

LIMITED LIABILITY COMPANY AGREEMENT OF ONCOSPIRE GENOMICS, LLC (Filed With SEC on July 12, 2013)

JOINT DEVELOPMENT INTELLECTUAL PROPERTY AGREEMENT (Filed With SEC on July 12, 2013)

AMENDMENT NO. 3 TO AFFILIATION AGREEMENT (Filed With SEC on June 5, 2013)

UNDERWRITING AGREEMENT between CANCER GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters CANCER GENETICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on March 22, 2013)

Exhibit A Effect of Reverse Splits on Warrant (Filed With SEC on March 4, 2013)

AMENDMENT NO. 2 TO AFFILIATION AGREEMENT (Filed With SEC on January 8, 2013)

UNDERWRITING AGREEMENT between CANCER GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on December 14, 2012)

DECEMBER 2012 CREDIT AGREEMENT (Filed With SEC on December 14, 2012)

PROMISSORY NOTE (Filed With SEC on December 14, 2012)

EIGHTH ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on November 16, 2012)

CANCER GENETICS, INC. AMENDED AND RESTATED 2008 STOCK OPTION PLAN (Filed With SEC on October 23, 2012)

CANCER GENETICS, INC. AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN (Filed With SEC on October 23, 2012)

CONFIDENTIAL SETTLEMENT AGREEMENT AND RELEASE OF ALLCLAIMS (Filed With SEC on October 23, 2012)

AMENDMENT NO. 1 TO AFFILIATION AGREEMENT (Filed With SEC on October 23, 2012)

STOCK PURCHASE WARRANT To Purchase Common Stock of CANCER GENETICS, INC. (Filed With SEC on October 23, 2012)

RESTATED CREDIT AGREEMENT (Filed With SEC on October 23, 2012)

RESTATED PROMISSORY NOTE (Filed With SEC on October 23, 2012)

STOCK PURCHASE WARRANT To Purchase Common Stock of CANCER GENETICS, INC. (Filed With SEC on October 23, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 23, 2012)

CANCER GENETICS, INC. Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 23, 2012)

OFFICE LEASE AGREEMENT BETWEEN MEADOWS OFFICE, L.L.C. AS LANDLORD AND CANCER GENETICS, INC. AS TENANT DATED OCTOBER 9, 2007 TABLE OF CONTENTS (Filed With SEC on April 23, 2012)

900 Route 9 North Suite 301 Woodbridge, NJ 07095 phone: (732) 362-8800 fax ###-###-#### www.onyxequities.com (Filed With SEC on April 23, 2012)

AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on March 13, 2012)

PROMISSORY NOTE (Filed With SEC on March 13, 2012)

STOCK PURCHASE WARRANT To Purchase Common Stock of CANCER GENETICS, INC. (Filed With SEC on March 13, 2012)

INTER-CREDITOR AGREEMENT CANCER GENETICS, INC. (Filed With SEC on March 13, 2012)

SEVENTH ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on March 13, 2012)

AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on March 13, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on February 14, 2012)

CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 30, 2011)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on December 30, 2011)

AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on December 30, 2011)

AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on December 30, 2011)

SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)

AMENDMENT AND WAIVER TO SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)

FORM OF SHORT FORM WARRANT TO PURCHASE COMMON STOCK OF CANCER GENETICS, INC. (Filed With SEC on December 30, 2011)

FORM OF MEDIUM FORM WARRANT TO PURCHASE COMMON STOCK OF CANCER GENETICS, INC. (Filed With SEC on December 30, 2011)

FORM OF LONG FORM WARRANT TO PURCHASE COMMON STOCK OF CANCER GENETICS, INC. (Filed With SEC on December 30, 2011)

CANCER GENETICS, INC. CONVERTIBLE PROMISSORY NOTE 1 (Note) (Filed With SEC on December 30, 2011)

2008 STOCK OPTION PLAN (Filed With SEC on December 30, 2011)

FORM OF NOTICE OF STOCK OPTION GRANT (Filed With SEC on December 30, 2011)

FORM OF STOCK OPTION AGREEMENT (Filed With SEC on December 30, 2011)

FORM OF EXERCISE NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)

CANCER GENETICS, INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on December 30, 2011)

STOCK OPTION GRANT AGREEMENT pursuant to the CANCER GENETICS, INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on December 30, 2011)

INDEMNIFICATION AGREEMENT (Filed With SEC on December 30, 2011)

TSG 1230 Peachtree St. NE, 24th Floor, Atlanta, GA 30309, USA Panna Sharma, CEO & Managing Partner ***@*** CONFIDENTIAL MATERIAL -2- (Filed With SEC on December 30, 2011)

MEDICAL DIRECTOR AGREEMENT (Filed With SEC on December 30, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on December 30, 2011)

CONSULTING AGREEMENT (Filed With SEC on December 30, 2011)

Cancer Genetics, Inc. 201 Route 17 North, 2nd Floor Rutherford, NJ 07675 (Filed With SEC on December 30, 2011)

CONSULTING AGREEMENT (Filed With SEC on December 30, 2011)

TSG Atlanta | Boston | New York, Laura White ***@*** (Filed With SEC on December 30, 2011)

FIRST ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

SECOND ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

THIRD ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

FOURTH ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

FIFTH ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

INTER-CREDITOR AGREEMENT CANCER GENETICS, INC. (Filed With SEC on December 30, 2011)

GENERAL BUSINESS SECURITY AGREEMENT (Filed With SEC on December 30, 2011)

PROMISSORY NOTE (Filed With SEC on December 30, 2011)

SIXTH ADDENDUM TO CREDIT AGREEMENT (Filed With SEC on December 30, 2011)

AFFILIATION AGREEMENT (Filed With SEC on December 30, 2011)

CANCER GENETICS, INC (175)